Roche Advances Diabetes Management by Integrating CGM Data for Personalized Therapy

Published on
By : Suvarna Sheth

Roche and Senseonics Incorporated are teaming up to implement the next step in data integration of the long-term Eversense Continuous Glucose Monitoring (CGM) system with Roche’s suite of digital diabetes management solutions.

The integration will allow for the real-time CGM data to be synchronized so Eversense users and their physicians will be able to review glucose values as well as related data online and on their mobile phones using the mySugr app or Accu-Chek Smart Pix.

“Expanding our longstanding relationship with Senseonics by incorporating data generated via the Eversense and Eversense XL CGM sensors into our digital solutions is an important step in moving our open ecosystem forward,” said Marcel Gmuender, Global Head of Roche Diabetes Care in a statement.

“Doing so, we continue to embrace our vision to bring innovation by means of truly integrated diabetes management solutions to the market, empowering people with diabetes to confidently manage their therapy routines every day and helping them experience true relief,” he adds.

The partnership between the two companies means people with diabetes and their physicians will be able to view real-time glucose information and related data both on Roche’s apps and web-based solutions in addition to the Eversense app.

The data integration will unlock data access for users and thus support improved therapy decisions.

“Partnering with Roche and being part of its open ecosystem for personalized diabetes management is a good fit with our strategy of giving people with diabetes the tools to use valuable health data for making actionable and informed therapy decisions,” states Dr. Tim Goodnow, president and, CEO of Senseonics.

The initial data integration is planned to be available to users beginning in 2019.